New Key Statistics Module, Z-Score and F-Score
NAS:INO Key Ratios
| Market Cap $ M | 273.83 |
| Enterprise Value $ M | 158.75 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.05 |
| Price/Sales | 285.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -6.09 |
| Beneish M-Score | -3.06 |
| 10-y EBITDA Growth Rate % | -5.80 |
| 5-y EBITDA Growth Rate % | 8.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.19 |
| EV-to-EBITDA | -1.22 |
| PEG | -- |
| Shares Outstanding M | 25.91 |
| Net Margin (%) | -16,240.14 |
| Operating Margin % | -16,036.90 |
| Pre-tax Margin (%) | -16,240.14 |
| Quick Ratio | 3.60 |
| Current Ratio | 3.60 |
| ROA % (ttm) | -55.73 |
| ROE % (ttm) | -79.81 |
| ROIC % (ttm) | -242.41 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.03 |
INO Number of Guru Trades
INO Volume of Guru Trades
Gurus Latest Trades with NAS:INO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:INO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Inovio Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:INO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers